Robert Whitfield MDAmerica's Breast Implant Illness Expert™

GLP-1s: Concerns & Alternatives to Appetite Control, What You Need to Know! #shorts

1 Nov 2025 · 1 min

Watch on YouTube

0:51

A clinician (Robert Whitfield MD) raises concerns about GLP-1 medications when used in non-diabetic people, noting there are no studies on effects in that population and questioning potential impacts on insulin production and future insulin resistance. He states GLP-1s affect the pancreas and suggests exploring other ways to reduce appetite, noting the personal benefit of reduced food preoccupation.

Chapters

You know, I don't think they knew what was going to happen. But here's the other part that I'm concerned about and that is that we've never studied this with people that are non diabetics. So what is going to happen with insulin production? What's going to happen on the other side of all this? The speculation is that we're going to have more insulin resistance in people that perhaps were not insulin resistant when we started this. It's hard to know, but we don't have any data to support that because we are affecting the pancreas. I mean, that's a reality with the GLP1s. And you know, if there's any other way for us to do it, wouldn't that be more appropriate to really help people? We want to help people. We want to help them with their appetite because that's clearly what's happened with the GLP1s. Thank God I'm not thinking about food all the time anymore. So the question's going to be, are there other ways to do that? And I think there are.